Literature DB >> 28553369

Efficacy comparison of lyophilised black raspberries and combination of celecoxib and PBIT in prevention of carcinogen-induced oesophageal cancer in rats.

Ni Shi1,2, Kenneth M Riedl3,2, Steven J Schwartz3,2, Xiaoli Zhang4,2, Steven K Clinton1,2, Tong Chen1,2.   

Abstract

The objective of this study was to compare the efficacy and mechanism of lyophilized black raspberries (BRB) versus the combination of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, and S,S'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea (PBIT), a selective inducible nitric oxide synthase (iNOS) inhibitor in inhibition of carcinogen-induced esophageal squamous cell carcinoma in rats. Our data indicated that tumor multiplicity and histologic grade of esophageal precancerous lesions were reduced in animals fed BRB compared to those fed celecoxib + PBIT. The mechanistic studies showed that BRB and its major anthocyanin suppressed cell proliferation and oncogenic signaling. Our findings demonstrated that dietary BRB is superior to the combination of two pharmaceutical drugs in esophageal cancer prevention. These observations suggest the potential value of translational studies using BRB food products for esophageal cancer prevention in humans, particularly those with high-risk premalignant lesions.

Entities:  

Keywords:  anthocyanin; black raspberries; cancer prevention; esophageal cancer

Year:  2016        PMID: 28553369      PMCID: PMC5441231          DOI: 10.1016/j.jff.2016.08.044

Source DB:  PubMed          Journal:  J Funct Foods        ISSN: 1756-4646            Impact factor:   4.451


  36 in total

1.  Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS.

Authors:  Tong Chen; Miranda E Rose; Hyejeong Hwang; Ronald G Nines; Gary D Stoner
Journal:  Carcinogenesis       Date:  2006-06-15       Impact factor: 4.944

2.  Black raspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells.

Authors:  Nancy N Zikri; Kenneth M Riedl; Li-Shu Wang; John Lechner; Steven J Schwartz; Gary D Stoner
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

3.  Anthocyanins from black rice (Oryza sativa L.) demonstrate antimetastatic properties by reducing MMPs and NF-κB expressions in human oral cancer CAL 27 cells.

Authors:  Ming-Jen Fan; I-Chen Wang; Yung-Ting Hsiao; Hui-Yi Lin; Nou-Ying Tang; Tzu-Chieh Hung; Christine Quan; Jin-Cherng Lien; Jing-Gung Chung
Journal:  Nutr Cancer       Date:  2015-02-06       Impact factor: 2.900

4.  Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population.

Authors:  G-Q Wang; C C Abnet; Q Shen; K J Lewin; X-D Sun; M J Roth; Y-L Qiao; S D Mark; Z-W Dong; P R Taylor; S M Dawsey
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

5.  Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.

Authors:  Ai-Wen Wu; Jin Gu; Jia-Fu Ji; Zhen-Fu Li; Guang-Wei Xu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun.

Authors:  Tong Chen; Hyejeong Hwang; Miranda E Rose; Ronald G Nines; Gary D Stoner
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

7.  Fruit and vegetable intake and esophageal cancer in a large prospective cohort study.

Authors:  Neal D Freedman; Yikyung Park; Amy F Subar; Albert R Hollenbeck; Michael F Leitzmann; Arthur Schatzkin; Christian C Abnet
Journal:  Int J Cancer       Date:  2007-12-15       Impact factor: 7.396

8.  Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Authors:  Craig A Elmets; Jaye L Viner; Alice P Pentland; Wendy Cantrell; Hui-Yi Lin; Howard Bailey; Sewon Kang; Kenneth G Linden; Michael Heffernan; Madeleine Duvic; Ellen Richmond; Boni E Elewski; Asad Umar; Walter Bell; Gary B Gordon
Journal:  J Natl Cancer Inst       Date:  2010-11-29       Impact factor: 13.506

9.  Anthocyanins From the Fruit of Vitis coignetiae Pulliat Potentiate the Cisplatin Activity by Inhibiting PI3K/Akt Signaling Pathways in Human Gastric Cancer Cells.

Authors:  Jing Nan Lu; Won Sup Lee; Arulkumar Nagappan; Seong-Hwan Chang; Yung Hyun Choi; Hye Jung Kim; Gon Sup Kim; Chung Ho Ryu; Sung Chul Shin; Jin-Myung Jung; Soon Chan Hong
Journal:  J Cancer Prev       Date:  2015-03

10.  Overexpression of human β-defensin 2 promotes growth and invasion during esophageal carcinogenesis.

Authors:  Ni Shi; Feng Jin; Xiaoli Zhang; Steven K Clinton; Zui Pan; Tong Chen
Journal:  Oncotarget       Date:  2014-11-30
View more
  4 in total

1.  Suppression of Oxidative Stress and NFκB/MAPK Signaling by Lyophilized Black Raspberries for Esophageal Cancer Prevention in Rats.

Authors:  Ni Shi; Fang Chen; Xiaoli Zhang; Steven K Clinton; Xiaofei Tang; Zheng Sun; Tong Chen
Journal:  Nutrients       Date:  2017-04-22       Impact factor: 5.717

2.  Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway.

Authors:  Ni Shi; Hao Yu; Tong Chen
Journal:  Onco Targets Ther       Date:  2019-09-17       Impact factor: 4.147

Review 3.  Onion anthocyanins: Extraction, stability, bioavailability, dietary effect, and health implications.

Authors:  Mahesh Kumar Samota; Madhvi Sharma; Kulwinder Kaur; Dinesh Kumar Yadav; Abhay K Pandey; Yamini Tak; Mandeep Rawat; Julie Thakur; Heena Rani
Journal:  Front Nutr       Date:  2022-07-27

Review 4.  Chemopreventive Effect of Dietary Anthocyanins against Gastrointestinal Cancers: A Review of Recent Advances and Perspectives.

Authors:  K V Surangi Dharmawansa; David W Hoskin; H P Vasantha Rupasinghe
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.